ACCORD BIOPHARMA
LIVE

Serial Number

97298517

Owner

ACCORD BIOPHARMA, INC.

Attorney

Michele K. Robichaux

First Use Date

Nov 19, 2019

Filing Date

Mar 7, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ACCORD BIOPHARMA Trademark

Serial Number: 97298517 • Registration: 7592997

ACCORD BIOPHARMA is a trademark filed by ACCORD BIOPHARMA, INC. on March 7, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ACCORD BIOPHARMA, INC. (28 trademarks)

1009 SLATER ROAD, SUITE 210
DURHAM, NC 27703

Entity Type: 03

Trademark Details

Filing Date

March 7, 2022

Registration Date

December 10, 2024

First Use Anywhere

November 19, 2019

First Use in Commerce

November 19, 2019

Published for Opposition

September 10, 2024

Goods & Services

A full line of medicated and pharmaceutical preparations, namely, pharmaceutical preparations and substances for use in the prevention, treatment and management of cancer, autoimmune diseases, immunological deficiency syndromes in the nature of autoimmune diseases, and critical illnesses in the nature of immune system related diseases and disorders for use in connection with humans

Providing healthcare and medical information; Providing information in the fields of Oncology, Immunology, and Critical Care

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 17, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 17, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 17, 2025 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 10, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 10, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 10, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 10, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 21, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 6, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 3, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 3, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 3, 2024 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 1, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 1, 2024 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 8, 2023 GNFN
FINAL REFUSAL E-MAILED
Nov 8, 2023 GNFR
FINAL REFUSAL WRITTEN
Nov 8, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 28, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 27, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 27, 2023 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 24, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
May 24, 2023 GNSL
SUSPENSION LETTER WRITTEN
May 24, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 19, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 19, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 19, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 3, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 3, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 5, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jan 5, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jan 5, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 17, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 11, 2022 NWOS
NEW APPLICATION ENTERED
Mar 10, 2022 NWAP